Cargando…
Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker
BACKGROUND: Conventional approaches to understand mechanisms underlying the development of pathological manifestations in ulcerative colitis (UC) mostly rely on identification of certain cell types and cytokines followed by verification of their roles in vitro and in vivo. In light of the highly dyn...
Autores principales: | Föhlinger, M., Palamides, P., Mansmann, U., Beigel, F., Siebeck, M., Gropp, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094062/ https://www.ncbi.nlm.nih.gov/pubmed/27809916 http://dx.doi.org/10.1186/s12967-016-1048-9 |
Ejemplares similares
-
A mouse model for ulcerative colitis based on NOD-scid IL2R γ(null) mice reconstituted with peripheral blood mononuclear cells from affected individuals
por: Palamides, Pia, et al.
Publicado: (2016) -
CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis
por: Al-amodi, Omar, et al.
Publicado: (2018) -
Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model
por: Jodeleit, Henrika, et al.
Publicado: (2017) -
Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis
por: Jodeleit, Henrika, et al.
Publicado: (2020) -
Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
por: Jodeleit, Henrika, et al.
Publicado: (2018)